Inmune Bio, Inc.
INMB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001711754
No open-market purchases or sales by Inmune Bio, Inc. insiders were filed in the last 90 days; 82 institutions reported holding it in 13F filings for Q2 2026, worth $7.08M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Inmune Bio, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 73 | 1 | 82 | +10 |
| Shares | 6.33M | 16.5K | 6.17M | −145.8K (−2.3%) |
| Value | $29.5M | $77.1K | $48.1M | +$18.7M (+63.3%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Inmune Bio, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Waratah Capital Advisors Ltd. | 53,774 | $420.0K | 0.03% |
| Simplex Trading, LLC | 42,809 | $334.0K | 0.01% |
| Cambridge Investment Research Advisors, Inc. | 23,075 | $180.0K | 0.00% |
| Commonwealth Equity Services, LLC | 19,888 | $155.0K | 0.00% |
| Wolverine Trading, LLC | 19,392 | $145.8K | 0.00% |
| Jane Street Group, LLC | 18,159 | $141.8K | 0.00% |
| PharVision Advisers, LLC | 17,241 | $134.7K | 0.19% |
| Nuveen, LLC | 16,518 | $129.0K | 0.00% |
| Group One Trading, L.P. | 15,526 | $121.3K | 0.01% |
| Quadrature Capital Ltd | 12,301 | $95.8K | 0.00% |
| Buckingham Strategic Partners | 11,589 | $90.5K | 0.00% |
| Quarry LP | 6,093 | $47.6K | 0.01% |
| Police & Firemen's Retirement System of New Jersey | 3,357 | $26.2K | 0.00% |
| Steward Partners Investment Advisory, LLC | 350 | $2.73K | 0.00% |
| NBC Securities, Inc. | 270 | $2.00K | 0.00% |
| Coldstream Capital Management Inc | 145 | $1.13K | 0.00% |
| GAMMA Investing LLC | 44 | $344 | 0.00% |
| EverSource Wealth Advisors, LLC | 9 | $70 | 0.00% |
Sold out (8)
Institutions that held Inmune Bio, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Renaissance Technologies LLC | 185,800 | $867.7K |
| Walleye Capital LLC | 33,719 | $157.5K |
| LPL Financial LLC | 19,072 | $89.1K |
| Mariner, LLC | 13,836 | $64.6K |
| Qube Research & Technologies Ltd | 13,298 | $62.1K |
| Two Sigma Advisers, LP | 12,700 | $59.3K |
| Prelude Capital Management, LLC | 12,406 | $57.9K |
| R Squared Ltd | 860 | $4.02K |
Not filed for Q1 2025 yet (1)
Institutions that held Inmune Bio, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 16,518 | $77.1K |